Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 131-137

  Gordon, David A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARRIER PROTEIN; LIPID; OLEIC ACID; VERY LOW DENSITY LIPOPROTEIN;

AMINO TERMINAL SEQUENCE; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HEPATOMA CELL; HUMAN; LIPID COMPOSITION; LIPID TRANSPORT; LIPOPROTEIN SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SECRETION; REVIEW;

ANIMALS; APOLIPOPROTEINS B; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; GLYCOPROTEINS; HUMANS; MICROSOMES; MODELS, BIOLOGICAL; PROTEIN BIOSYNTHESIS; TRIGLYCERIDES;

EID: 0030859321     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00002     Document Type: Review

References (41)

1. Wetterau JR, Zilversmitt DB: A triglyceride and cholesteryl ester transfer protein associated with liver microsomes. J Biol Chem 1984, 259:10863-10866.
2. Wetterau JR, Zilversmitt DB: Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues. Biochim Biophys Acta 1986, 875:610-617.
3. Jamil H, Dickson JK, Chu C-H, Lago MW, Rinehart JK, Biller SA, Gregg RE, Wetterau JR: Microsmal triglyceride transfer protein: specificity of lipid binding and transport. J Biol Chem 1995, 270:6549-6554.
4. Wetterau JR, Combs KA, Spinner SN, Joiner BJ: Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J Biol Chem 1990, 265:9800-9807.
5. Wetterau JR, Lin MCM, Jamil H: Microsomal triacylglycerol transfer protein. Biochim Biophys Acta 1997, 1345 (In press).
6. Kane JP, Havel RJ: Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In The metabolic basis of inherited disease, edn 6. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 1989:1139-1164.
7. Wetterau JR, Aggerbeck LP, Bouma M-E, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE: Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258:999-1001.
8. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, Gil CM, Turck CW, Bouma M-E, Rader DJ et al.: Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature 1993, 365:65-69.
9. Shoulders CC, Brett DJ, Bayliss JD, Narcisi TME, Jarmuz A, Grantham TT, Leoni PRD, Bhattacarya S, Pease RJ, Cullen PM et al.: Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet 1993, 2:2109-2116.
10. Narcisi TM, Shoulders CC, Chester SA, Read J, Grett DJ, Harrison GB, Grantham TT, Fox MF, Povey S, de Bruin TW et al.: Mutations of the microsomal triglyceride transfer protein gene in abetalipoproteinemia. Am J Hum Genet 1995, 57:1298-1310.
11. Ricci B, Sharp D, O'Rourke E, Kienzle B, Blinderman L, Gordon D, Smith-Monroy C, Robinson G, Gregg RE, Rader DJ, Wetterau JR: A 30 amino acid truncation of the microsoma triglyceride transfer protein large subunit disrupts its interaction with protein disulfide isomerase and causes abetalipoproteinemia. J Biol Chem 1995, 270:14281-14285.
12. Rehberg EF, Samson-Bouma M-E, Kienzle B, Blinderman L, Jamil H, Wetterau JR, Aggerbeck LP, Gordon DA: A novel abetalipoproteinemia genotype; identification of a missense mutation in the 97 kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein disulfide isomerase. J Biol Chem 1996, 271:29945-29952.
13. Segrest JP, Jones MK, Mishra VK, Anantharamaiah GM, Garber DW: ApoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by the computer program LOCATE. Arterioscler Thromb 1994, 14:1674-1685.
14. Yang C-Y, Kim TW, Weng S-A, Lee B, Yang M, Gotto AM: Isolation and characterization of sulfhydryls and disulfide peptides of human apolipoprotein B-100. Proc Natl Acad Sci U S A 1990, 87:5523-5527.
15. Alexander CA, Hamilton RL, Havel RJ: Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. J Cell Biol 1976, 69:241-263.
16. Borén J, Rustaeus S, Olofsson S-O: Studies on the assembly of apolipoprotein B-100 and B-48-containing very low density lipoprotein in McArdle RH-7777 cells. J Biol Chem 1994, 269:25879-25888.
17. Gordon DA, Jamil H, Sharp D, Mullaney D, Yao Z, Gregg RE, Wetterau J: Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad Sci U S A 1994, 91:7628-7632.
18. Leiper JM, Bayliss JD, Pease RJ, Brett DJ, Scott J, Shoulders CC: Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. J Biol Chem 1994, 269:21951-21954.
19. 29 require MTP for efficient secretion, whereas those smaller do not. Also presented are data describing a physical interaction between MTP and apoB.
20. 48 size. Coexpression of MTP greatly reduces the formation of this product and reduces the sensitivity of microsomal apoB to exogenous trypsin. This suggests that MTP stabilizes apoB during assembly, perhaps by assisting translocation into the ER lumen.
21. 100 are secreted in the absence of MTP as HDL density particles. Coexpression of MTP enhanced the number of particles secreted but did not change the density. Removal of the amino terminus from various segments of apoB covering the entire polypeptide blocked secretion regardless of MTP coexpression, indicating that the amino terminus of apoB is necessary but not sufficient for MTP responsiveness.
22. 100 as a lipoprotein particle. The authors concluded that disruption of the disulfide bonding of the amino terminus of apoB by dithiothreitol blocks formation of the lipid-binding domains, rendering them incapable of receiving lipid from MTP causing lipoprotein assembly to halt. Thus the proper folding of the amino terminus of apoB is critical for the proper folding of the subsequent sequences.
23. Tanabe S, Sherman H, Smith L, Yang L-A, Fleming R, Hay R: Biogenesis of plasma lipoproteins in rat hepatoma McA-RH7777: importance of diffusion-mediated events during cell growth. In Vitro Cell Dev Biol 1989, 25:1129-1140.
24. 48 primordial precursor particles is not blocked on activation of the second step.
25. 50 of 5.0 μmol/l. Inhibitor treatment does not effect lipid synthesis or change apoB mRNA levels. The degradation rate of full-length apoB was increased slightly in inhibitor-treated cells versus controls.
26. 50 of 1.8 μmol/l. Pulse-chase analyses showed that secretion was blocked as early as 20 min after addition of the compound.
27. 50 of 0.3 μmol/l. No effect on lipid synthesis was detectable. Pulse-chase analyses showed that although apoB synthesis was inhibited it did not accumulate in the cells. This was attributable to increased cotranslational or immediate posttranslational degradation of apoB. The effect of the inhibitor on apoB degradation could be blocked with dithiothreitol but not N-acetyl-leucyl-leucyl-norleucinal.
28. Wu X, Sakata N, Lele KM, Zhou M, Ginsberg HN: A two site model for apoB degradation in HepG2 cells. J Biol Chem 1997 (In press).
29. Wu X, Zhou M, Huang LS, Wetterau J, Ginsberg HN: Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of apoB-containing lipoproteins. J Biol Chem 1996, 271:10277-10281. This report was the first to provide evidence for a direct physical interaction between MTP and apoB. Immunoprecipitation of hepatoma G2 extracts with an antibody to MTP also precipitated apoB. Pulse-chase analyses showed that this association was detectable only during the first 10 min of chase. Oleic acid treatment increased the extent of association, and the time, while inhibition of triglyceride synthesis with Triacsin D decreased these parameters. Treatment with N-acetyl-leucyl-leucyl-norleucinal to increase intracellular apoB increased the time but not the extent of interaction.
30. Atzel A, Wetterau JR: Mechanism of microsomal triglyceride transfer protein catalyzed lipid transport. Biochemistry 1993, 32:10444-10450.
31. 100 in abetalipoproteinemics. The authors concluded that this was because of a block in the translocation of apoB caused by the absence of MTP. This led to truncation of the nascent polypeptide and release of the amino terminus into the lumen of the ER from where it was secreted, albeit inefficiently.
32. 48 was shown to translocate in both systems with similar efficiency indicating that MTP is probably not required for the translocation per se of apoB.
33. 4a membrane interactions: absence of transmembrane localization in non-hepatic cells. J Biol Chem 1994, 269:9310-9318.
34. Herscovitz H, Kritis A, Talianidis I, Zanni E, Zannis V, Small DM: Murine mammary-derived cells secrete the N-terminal 41% of human apolipoprotein B on high density lipoprotein-sized lipoproteins containing a triacylglycerol-rich core. Proc Natl Acad Sci U S A 1995, 92:659-663.
35. Leiper JM, Harrison GB, Bayliss JD, Scott, J, Pease RJ: Systematic expression of the complete coding sequence of apoB-100 does not reveal transmembrane determinants. J Lipid Res 1996, 37:2215-2231.
36. Ingram MF, Shelness GS: Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane. J Lipid Res 1996, 37:2202-2214.
37. Chuck SL, Lingappa VR: Pause transfer: a topogenic sequence in apolipoprotein B mediates stopping and restarting of translocation. Cell 1992, 68:9-21.
38. Du EZ, Kurth J, Wang SL, Humiston P, Davis RA: Proteolysis-coupled secretion of the N terminus of apolipoprotein B. Characterization of a transient translocation arrested intermediate. J Biol Chem 1994, 39:24169-24176.
39. Hiller MM, Finger A, Schweiger M, Wolf DG: ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteosome pathway. Science 1996, 273:1725-1728.
40. Yeung SJ, Chen SH, Chan L: Ubiquitin-proteosome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry 1996, 35:13843-13848.
41. 100-containing lipoproteins in HepG2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly. J Biol Chem 1990, 265:10556-10564.